Cancer experts are optimistic about a recent breakthrough in cancer vaccine development. A new vaccine has shown promise, marking a significant milestone after a century of unsuccessful attempts.

This achievement is seen as the start of a new era in cancer treatment, with custom-made vaccines that can be tailored to individual patients.

Further details about this breakthrough are available, including the collaboration between pharmaceutical companies Moderna and Merck that led to this success.